These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9652605

  • 1. Insulin-sensitising agents in polycystic-ovary syndrome.
    Sattar N, Hopkinson ZE, Greer IA.
    Lancet; 1998 Jan 31; 351(9099):305-7. PubMed ID: 9652605
    [No Abstract] [Full Text] [Related]

  • 2. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
    Kuscu NK, Koyuncu FM.
    Medscape Womens Health; 2002 Jan 31; 7(5):3. PubMed ID: 12466732
    [Abstract] [Full Text] [Related]

  • 3. The polycystic ovary syndrome: treatment with insulin sensitizing agents.
    Iuorno MJ, Nestler JE.
    Diabetes Obes Metab; 1999 May 31; 1(3):127-36. PubMed ID: 11220291
    [No Abstract] [Full Text] [Related]

  • 4. Insulin sensitizers for polycystic ovary syndrome.
    Baillargeon JP, Iuorno MJ, Nestler JE.
    Clin Obstet Gynecol; 2003 Jun 31; 46(2):325-40. PubMed ID: 12808383
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of hyperinsulinaemia in polycystic ovary syndrome?
    van Montfrans JM, van Hooff MH, Hompes PG, Lambalk CB.
    Hum Reprod; 1998 Jan 31; 13(1):5-6. PubMed ID: 9512218
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Troglitazone for treatment of polycystic ovary syndrome].
    Sanaka M, Iwamoto Y.
    Nihon Rinsho; 2000 Feb 31; 58(2):465-70. PubMed ID: 10707578
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Polycystic ovary syndrome.
    Ehrmann DA.
    N Engl J Med; 2005 Mar 24; 352(12):1223-36. PubMed ID: 15788499
    [No Abstract] [Full Text] [Related]

  • 13. Insulin-sensitizing agents in women with polycystic ovary syndrome.
    Pasquali R, Gambineri A.
    Fertil Steril; 2006 Jul 24; 86 Suppl 1():S28-9. PubMed ID: 16798283
    [Abstract] [Full Text] [Related]

  • 14. Troglitazone use in polycystic ovary syndrome.
    Landman RE, Jacobs TP.
    J Clin Endocrinol Metab; 2001 Oct 24; 86(10):5090-1. PubMed ID: 11600596
    [No Abstract] [Full Text] [Related]

  • 15. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ, Hutchison SK, Zoungas S.
    Trends Endocrinol Metab; 2007 Sep 24; 18(7):273-9. PubMed ID: 17698366
    [Abstract] [Full Text] [Related]

  • 16. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.
    Katsiki N, Hatzitolios AI.
    Curr Opin Obstet Gynecol; 2010 Dec 24; 22(6):466-76. PubMed ID: 20724929
    [Abstract] [Full Text] [Related]

  • 17. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
    Lord JM, Flight IH, Norman RJ.
    Cochrane Database Syst Rev; 2003 Dec 24; (3):CD003053. PubMed ID: 12917943
    [Abstract] [Full Text] [Related]

  • 18. Thiazolidinediones for treatment of polycystic ovary syndrome.
    Stout DL, Fugate SE.
    Pharmacotherapy; 2005 Feb 24; 25(2):244-52. PubMed ID: 15767238
    [Abstract] [Full Text] [Related]

  • 19. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.
    Sangraula H, Paudel KR, Sharma M.
    JNMA J Nepal Med Assoc; 2009 Feb 24; 48(176):335-9. PubMed ID: 21105563
    [Abstract] [Full Text] [Related]

  • 20. WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.
    Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD003053. PubMed ID: 19588338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.